These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29739692)

  • 1. Granulocyte and monocyte apheresis in inflammatory bowel disease: The patients' point of view.
    Rodríguez-Lago I; Benítez JM; García-Sánchez V; Gutiérrez A; Sempere L; Ginard D; Barreiro-de Acosta M; Cabriada JL
    Gastroenterol Hepatol; 2018; 41(7):423-431. PubMed ID: 29739692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: the first 100 patients treated in Scandinavia.
    Ljung T; Thomsen OØ; Vatn M; Karlén P; Karlsen LN; Tysk C; Nilsson SU; Kilander A; Gillberg R; Grip O; Lindgren S; Befrits R; Löfberg R
    Scand J Gastroenterol; 2007 Feb; 42(2):221-7. PubMed ID: 17327942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study.
    Passalacqua S; Ferraro PM; Bresci G; D'Ovidio V; Astegiano M; Principi M; Testa R; D'Incà R; Valpiani D; Armuzzi A; Sablich R; Cavallaro F; Costa F; Di Leo V; Colombo E; Santini A; Aratari A; Lecis P; Saladino V; Riegler G; Marco M; Calella F; Ricci C; Guidi ML; Repaci G; Silla M
    J Clin Apher; 2011 Dec; 26(6):332-7. PubMed ID: 22072543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective Single Center Study of Granulocyte Monocyte Adsorption Apheresis Treatment in Inflammatory Bowel Disease.
    Edfors K; Ståhlberg D; Söderman C
    Ther Apher Dial; 2016 Feb; 20(1):79-85. PubMed ID: 26841133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
    Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.
    Sands BE; Sandborn WJ; Feagan B; Löfberg R; Hibi T; Wang T; Gustofson LM; Wong CJ; Vandervoort MK; Hanauer S;
    Gastroenterology; 2008 Aug; 135(2):400-9. PubMed ID: 18602921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of granulocyte and monocyte adsorption apheresis for ulcerative colitis: a meta-analysis.
    Yoshino T; Nakase H; Minami N; Yamada S; Matsuura M; Yazumi S; Chiba T
    Dig Liver Dis; 2014 Mar; 46(3):219-26. PubMed ID: 24268950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Granulocyte-monocyte apheresis for the treatment of inflammatory bowel disease].
    ; Passalacqua S; Ferraro PM
    G Ital Nefrol; 2012; 29 Suppl 54():S61-3. PubMed ID: 22388832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting clinical and endoscopic efficacies of selective leucocytapheresis for ulcerative colitis.
    Yamamoto T; Saniabadi AR; Maruyama Y; Umegae S; Matsumoto K
    Dig Liver Dis; 2007 Jul; 39(7):626-33. PubMed ID: 17532273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis.
    D'Ovidio V; Aratari A; Viscido A; Marcheggiano A; Papi C; Capurso L; Caprilli R
    Dig Liver Dis; 2006 Jun; 38(6):389-94. PubMed ID: 16569521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis.
    Andoh A; Tsujikawa T; Inatomi O; Deguchi Y; Hata K; Kitoh K; Sasaki M; Mitsuyama K; Fujiyama Y
    Ther Apher Dial; 2005 Apr; 9(2):123-7. PubMed ID: 15828923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and safety of selective granulocyte and monocyte apheresis for inflammatory bowel disease: A meta-analysis.
    Liu Z; Jiang X; Sun C
    Eur J Intern Med; 2016 Dec; 36():e26-e27. PubMed ID: 27614377
    [No Abstract]   [Full Text] [Related]  

  • 13. Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study.
    Yamamoto T; Umegae S; Kitagawa T; Yasuda Y; Yamada Y; Takahashi D; Mukumoto M; Nishimura N; Yasue K; Matsumoto K
    Aliment Pharmacol Ther; 2004 Oct; 20(7):783-92. PubMed ID: 15379839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective granulocyte and monocyte apheresis as a new adjunct to enhance the efficacy of interferon-alpha + ribavirin in patients with high plasma hepatitis C virus.
    Sawada K; Kashiwamura S; Okamura H; Ohnishi K; Fukunaga K; Hirata I; Saniabadi A
    Dig Liver Dis; 2005 Jul; 37(7):515-21. PubMed ID: 15975539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcerative colitis and granulocyte-monocyte-apheresis: safety and efficacy of maintenance therapy during pregnancy.
    D'Ovidio V; Meo D; Gozer M; Bazuro ME; Vernia P
    J Clin Apher; 2015 Feb; 30(1):55-7. PubMed ID: 25181523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective leukocyte apheresis for the treatment of inflammatory bowel disease.
    Abreu MT; Plevy S; Sands BE; Weinstein R
    J Clin Gastroenterol; 2007; 41(10):874-88. PubMed ID: 18090155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel Disease.
    Sáez-González E; Moret I; Alvarez-Sotomayor D; Díaz-Jaime FC; Cerrillo E; Iborra M; Nos P; Beltrán B
    Dig Dis Sci; 2017 Jun; 62(6):1417-1425. PubMed ID: 28432476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a Novel Granulocyte Monocyte Apheresis Adsorber Device in the Treatment of Inflammatory Bowel Diseases: A Pilot Study.
    Di Girolamo M; Sartini A; Critelli R; Bertani A; Merighi A; Villa E
    Ther Apher Dial; 2016 Dec; 20(6):668-676. PubMed ID: 27921374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.
    Schultheiß C; Weischenberg R; Herrmann A; Haller B; Schmid RM; Reindl W; Huber W
    Artif Organs; 2015 Feb; 39(2):187-92. PubMed ID: 24981894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary data on the use of apheresis in inflammatory bowel disease.
    Sandborn WJ
    Inflamm Bowel Dis; 2006 Jan; 12 Suppl 1():S15-21. PubMed ID: 16378006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.